EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method

Wenjie Chen iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0323816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Wenjie Chen. Beteiligte Einrichtung: Laboratory for Protein Crystallography, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, UCL Medical School Royal Free Campus, …. Hauptthemen laut MEDLINE: Prealbumin, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College London, Selcia Ltd UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A Capillary Zone Electrophoresis (CZE) fragment screening methodology was developed and applied to the human plasma protein Transthyretin (TTR), normally soluble, but could misfold and aggregate, causing amyloidosis. Termed Free Probe Peak Height Restoration (FPPHR), it monitors changes in the level of free ligand known to bind TTR (the Probe Ligand) in the presence of competing fragments. 129 fragments were screened, 12 of the 16 initial hits (12.4% hit rate) were co-crystallised with TTR, 11 were found at the binding site (92% confirmation rate). Subsequent analogue screens have identified a novel TTR-binding scaffold 4-(3H-pyrazol-4-yl)quinoline and its derived compounds were further studied by crystallography, circular dichroism (CD), isothermal titration calorimetry (ITC) and radiolabelled 125 I-Thyroxine displacement assay in neat plasma. Two lead molecules had similar ITC K d and 125 I-Thyroxine displacement IC 50 values to that of Tafamidis, adding another potential pipeline for transthyretin amyloidosis. The methodology is reproducible, procedurally simple, automatable, label-free without target immobilisation, non-fluorescence based and site-specific with low false positive rate, which could be applicable to fragment screening of many drug targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrealbuminDrug DiscoveryHumansElectrophoresis, CapillaryKineticsBenzoxazolesQuinolinesProtein BindingBinding SitesAmyloid Neuropathies, Familial

Substanzen

PrealbumintafamidisBenzoxazolesQuinolinesTTR protein, human

Autor:innen und Institutionen

  • Laboratory for Protein Crystallography, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, UCL Medical School Royal Free Campus, London, United Kingdom.

ORCID-Profile: Wenjie Chen

Förderung

  • University College London
  • Selcia Ltd UK

Zitieren

APA

Chen, W. (2025). Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method. PLOS One. https://doi.org/10.1371/journal.pone.0323816

Vancouver

Chen W. Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method. PLOS One. 2025. doi:10.1371/journal.pone.0323816

BibTeX
@article{Chen2025,
  author = {Chen, Wenjie},
  title = {Fragment-based drug discovery for transthyretin kinetic stabilisers using a novel capillary zone electrophoresis method},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0323816}
}
Kostenlos starten →